DNAprint Genomics (DNAG)

[worktoplay]

Cosmic...

From the Moffitt Agreement:

3. FUNDING - Neither Party is obligated to fund the research of the other Party. Hence, Company and Moffitt shall each be responsible for their own expenses incurred in the performance of the Projects, unless otherwise agreed to in writing. Moffitt makes no representations that they will fund any clinical trials that may ensue from the Projects. Funding for the clinical trials will be dependent upon each Principal Investigator's ability to financially support such trials and or support from Company or another third party.

Funding for the research itself is on Moffitt and DNAPrint. The trials, however, are the responsibility of the Principal Investigator along with "support" from the Company or another third party (a pharma company perhaps?) if necessary.

Should be some interesting PR's coming out over the next month...

Later,
W2P